| .(2012): Reduced Mid1 expression and delayed neuromotor development in daDREAM transgenic mice M Dierssen, L Fedrizzi, R Gomez-Villafuertes, MM de Lagran, ... Front Mol Neurosci 5, 58, 0 | 2 | |
| 40th Biennial American Cytogenetics Conference G Mazzini, M Zuccotti, CA Redi, S Garagna, T Neri, ... Cytogenetic and Genome Research 121 (1), 78-78, 2008 | | 2008 |
| A behavioral assessment of Ts65Dn mice: a putative Down syndrome model RM Escorihuela, A Fernández-Teruel, IF Vallina, C Baamonde, ... Neuroscience letters 199 (2), 143-146, 1995 | 305 | 1995 |
| A cluster of protein kinases and phosphatases modulated in fetal Down syndrome (trisomy 21) brain R Weitzdoerfer, N Toran, S Subramaniyan, A Pollak, M Dierssen, G Lubec Amino Acids 47, 1127-1134, 2015 | 5 | 2015 |
| A commentary on: Overexpression of Dyrk1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome. M Dierssen Experimental neurology 247, 110-112, 2013 | 1 | 2013 |
| A deep learning approach to neurite prediction in high throughput fluorescence imaging M Barch, MM Cobb, Z Tokuno, J Leddy, K Prenton, L Manubens-Gil, ... bioRxiv, 2021.04. 23.441035, 2021 | 2 | 2021 |
| A dynamic in vitro model of Down Syndrome neurogenesis with Trisomy 21 gene dosage correction P Bansal, EC Banda, HR Glatt-Deeley, CE Stoddard, JW Linsley, N Arora, ... Science Advances 10 (23), eadj0385, 2024 | 2 | 2024 |
| A game theory based analysis of network connectivity reveals that state transition is crucial for epilepsy surgery outcome prediction K Ivankovic, A Principe, J Montoya, L Manubens-Gil, M Dierssen, ... medRxiv, 2021.11. 19.21266569, 2021 | | 2021 |
| A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain Y Sun, M Dierssen, N Toran, DD Pollak, WQ Chen, G Lubec Journal of proteomics 74 (4), 547-557, 2011 | 34 | 2011 |
| A geometric morphometrics and machine learning tool for facial shape analysis and classification based on non-invasive facial biomarkers: A Down’s syndrome case study X Sevillano, A González, R González, J Sharpe, R De La Torre, ... Training 95, 75SD, 0 | | |
| A highly conserved neuronal microexon in DAAM1 controls actin dynamics, RHOA/ROCK signaling, and memory formation P Poliński, M Miret Cuesta, A Zamora-Moratalla, F Mantica, ... bioRxiv, 2023.01. 12.523772, 2023 | | 2023 |
| A Morphometric Assessment of the Influence of EGCG on Down Syndrome Facial Morphology J Cintron, M Dierssen, R Gonzalez, J Sharpe, N Martinez‐Abadias, ... The FASEB Journal 33 (S1), 612.5-612.5, 2019 | | 2019 |
| A murine model for Down syndrome shows reduced responsiveness to pain C Martínez-Cué, C Baamonde, MA Lumbreras, IF Vallina, M Dierssen, ... Neuroreport 10 (5), 1119-1122, 1999 | 85 | 1999 |
| A new analytical pipeline reveals metatranscriptomic changes upon high-fat diet in a Down syndrome mouse model IE Grabowicz, J Herman-Iżycka, M Fructuoso, M Dierssen, B Wilczyński bioRxiv, 2021.12. 16.472765, 2021 | | 2021 |
| A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials S Sola Llopis, R Torre Fornell, G Sánchez Benavides, B Benejam, ... Frontiers in psychology. 2015; 6: 708, 2015 | | 2015 |
| A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials S de Sola, R de la Torre, G Sánchez-Benavides, B Benejam, ... Frontiers in psychology 6, 708, 2015 | 81 | 2015 |
| A new mouse model for the trisomy of the Abcg1–U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome PL Pereira, L Magnol, I Sahun, V Brault, A Duchon, P Prandini, A Gruart, ... Human molecular genetics 18 (24), 4756-4769, 2009 | 135 | 2009 |
| A novel regulatory mechanism of actin cytoskeleton dynamics through a neural microexon in DAAM1 is important for proper memory formation P Poliński, MM Cuesta, A Zamora-Moratalla, F Mantica, ... | | |
| A novel regulatory mechanism of actin cytoskeleton dynamics through a neural microexon in DAAM1 is necessary for memory formation P Poliński, MM Cuesta, A Zamora-Moratalla, F Mantica, ... bioRxiv, 2023 | | 2023 |
| A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome T Fornell, S De Sola Llopis, L Xicota Vila, AM Cuenca Royo, J Rodriguez, ... Elsevier, 2019 | | 2019 |
Xavier Estivill MD PhDqGenomics (Quantitative Genomics Laboratories)在 qgenomics.com 的电子邮件经过验证
